Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group
Titel:
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group
Auteur:
Fountzilas, G. Skarlos, D. Dafni, U. Gogas, H. Briasoulis, E. Pectasides, D. Papadimitriou, C. Markopoulos, C. Polychronis, A. Kalofonos, H.P. Siafaka, V. Kosmidis, P. Timotheadou, E. Tsavdaridis, D. Bafaloukos, D. Papakostas, P. Razis, E. Makrantonakis, P. Aravantinos, G. Christodoulou, C. Dimopoulos, A.-M.